Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure | Charles Explorer

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

Publikace na Fakulta tělesné výchovy a sportu |

2005

Abstrakt

eplerenone, acute myocardial infarction

Osoba